PDCI Market Access

PDCI Market Access is a premier Canadian consultancy specializing in pricing and market access strategies for the pharmaceutical and biotechnology sectors. Founded in 1996 and headquartered in Ottawa, the firm provides comprehensive services including Health Technology Assessment (HTA) submissions, PMPRB regulatory compliance, and pan-Canadian Pharmaceutical Alliance (pCPA) negotiation support. PDCI is widely recognized for its deep expertise in the Canadian payer landscape and its data-driven approach to reimbursement challenges. In 2020, the company was acquired by McKesson Canada, enhancing its ability to provide integrated market access solutions across the product lifecycle. The firm serves a diverse range of clients, from emerging biotechs to global pharmaceutical leaders, helping them navigate the complexities of the Canadian healthcare system.